DERM · Journey Medical Corporation Common Stock
View on chartInsiders & Stakes
| Claude Maraoui President & CEO | ▲ Buy | Grant | 2,435,990 Shares held | 4/22/2026 | View profile |
| Ramsey Alloush COO | ▲ Buy | Grant | 598,543 Shares held | 4/22/2026 | View profile |
| Joseph Benesch Interim CFO | ▲ Buy | Grant | 261,371 Shares held | 4/22/2026 | View profile |
| De Paolantonio Ernest Robert Chief Financial Officer | ▼ Sell | Open Market | 259,907 Shares held | 10/4/2022 | View profile |
| Justin Adam Smith Director | ▲ Buy | Grant | 231,618 Shares held | 7/1/2026 | View profile |
| Lindsay A. Rosenwald, MD Director | ▲ Buy | Grant | 221,146 Shares held | 6/25/2026 | View profile |
| Miranda Jayne Toledano Director | ▲ Buy | Grant | 168,618 Shares held | 7/1/2026 | View profile |
| Neil Herskowitz Director | ▲ Buy | Grant | 168,618 Shares held | 7/1/2026 | View profile |
| Paley Jeffrey Director | ▼ Sell | Open Market | 70,727 Shares held | 11/28/2023 | View profile |
| Michael Cooper Pearce Director | ▲ Buy | Grant | 67,173 Shares held | 6/25/2026 | View profile |
Transaction History
| Miranda Jayne Toledano | ▲ Buy | Grant | 50,000 | $0 | 7/1/2026 |
| Justin Adam Smith | ▲ Buy | Grant | 50,000 | $0 | 7/1/2026 |
| Neil Herskowitz | ▲ Buy | Grant | 50,000 | $0 | 7/1/2026 |
| Miranda Jayne Toledano | ▲ Buy | Grant | 10,000 | $0 | 6/25/2026 |
| Neil Herskowitz | ▲ Buy | Grant | 10,000 | $0 | 6/25/2026 |
| Michael Cooper Pearce | ▲ Buy | Grant | 10,000 | $0 | 6/25/2026 |
| Lindsay A. Rosenwald, MD | ▲ Buy | Grant | 10,000 | $0 | 6/25/2026 |
| Justin Adam Smith | ▲ Buy | Grant | 10,000 | $0 | 6/25/2026 |
| Claude Maraoui | ▲ Buy | Grant | 49,277 | $0 | 4/22/2026 |
| Ramsey Alloush | ▲ Buy | Grant | 46,863 | $0 | 4/22/2026 |
| Joseph Benesch | ▲ Buy | Grant | 28,907 | $0 | 4/22/2026 |
| Claude Maraoui | ▲ Buy | Option Exercise | 1,250,000 | $81K | 8/25/2025 |
| Claude Maraoui | ▼ Sell | Tax Withholding | 10,877 | $81K | 8/25/2025 |
| Justin Adam Smith | ▲ Buy | Grant | 20,000 | $0 | 8/5/2025 |
| Miranda Jayne Toledano | ▲ Buy | Grant | 20,000 | $0 | 8/5/2025 |
| Neil Herskowitz | ▲ Buy | Grant | 20,000 | $0 | 8/5/2025 |
| Lindsay A. Rosenwald, MD | ▲ Buy | Grant | 50,000 | $0 | 8/5/2025 |
| Michael Cooper Pearce | ▲ Buy | Grant | 20,000 | $0 | 8/5/2025 |
| Miranda Jayne Toledano | ▲ Buy | Grant | 7,173 | $0 | 6/25/2025 |
| Lindsay A. Rosenwald, MD | ▲ Buy | Grant | 7,173 | $0 | 6/25/2025 |
| Michael Cooper Pearce | ▲ Buy | Grant | 7,173 | $0 | 6/25/2025 |
| Justin Adam Smith | ▲ Buy | Grant | 7,173 | $0 | 6/25/2025 |
| Neil Herskowitz | ▲ Buy | Grant | 7,173 | $0 | 6/25/2025 |
| Ramsey Alloush | ▲ Buy | Grant | 46,863 | $0 | 6/17/2025 |
| Joseph Benesch | ▲ Buy | Grant | 28,907 | $0 | 6/17/2025 |
| Claude Maraoui | ▲ Buy | Grant | 49,277 | $0 | 6/17/2025 |
| Claude Maraoui | ▼ Sell | Open Market | 4,834 | $33K | 5/2/2025 |
| Joseph Benesch | ▼ Sell | Open Market | 2,409 | $16K | 5/2/2025 |
| Ramsey Alloush | ▼ Sell | Open Market | 2,857 | $20K | 5/2/2025 |
| Claude Maraoui | ▼ Sell | Open Market | 49,271 | $247K | 3/11/2025 |
| Claude Maraoui | ▼ Sell | Open Market | 14,905 | $75K | 3/7/2025 |
| Claude Maraoui | ▼ Sell | Open Market | 25,551 | $129K | 3/6/2025 |
| Claude Maraoui | ▼ Sell | Open Market | 18,147 | $93K | 3/5/2025 |
| Claude Maraoui | ▼ Sell | Open Market | 28,901 | $146K | 3/4/2025 |
| Claude Maraoui | ▼ Sell | Open Market | 23,508 | $122K | 3/3/2025 |
| Joseph Benesch | ▼ Sell | Open Market | 1,365 | $7K | 2/21/2025 |
| Joseph Benesch | ▼ Sell | Open Market | 9,324 | $51K | 8/1/2024 |
| Joseph Benesch | ▼ Sell | Open Market | 4,055 | $22K | 7/23/2024 |
| Michael Cooper Pearce | ▲ Buy | Grant | 30,000 | $0 | 7/19/2024 |
| Justin Adam Smith | ▲ Buy | Grant | 9,728 | $0 | 7/8/2024 |
| Neil Herskowitz | ▲ Buy | Grant | 9,728 | $0 | 7/8/2024 |
| Miranda Jayne Toledano | ▲ Buy | Grant | 9,728 | $0 | 7/8/2024 |
| Lindsay A. Rosenwald, MD | ▲ Buy | Grant | 9,728 | $0 | 7/8/2024 |
| Claude Maraoui | ▲ Buy | Grant | 175,000 | $0 | 5/1/2024 |
| Joseph Benesch | ▲ Buy | Grant | 80,000 | $0 | 5/1/2024 |
| Lindsay A. Rosenwald, MD | ▲ Buy | Open Market | 10,000 | $30K | 3/25/2024 |
| Claude Maraoui | ▲ Buy | Open Market | 10,000 | $35K | 3/22/2024 |
| Justin Adam Smith | ▲ Buy | Open Market | 30,000 | $104K | 3/22/2024 |
| Lindsay A. Rosenwald, MD | ▲ Buy | Open Market | 20,000 | $68K | 3/22/2024 |
| Joseph Benesch | ▼ Sell | Open Market | 2,450 | $9K | 2/22/2024 |
| Claude Maraoui | ▲ Buy | Grant | 175,000 | $0 | 1/3/2024 |
| Joseph Benesch | ▲ Buy | Grant | 80,000 | $0 | 1/3/2024 |
| Paley Jeffrey | ▼ Sell | Open Market | 1,745 | $9K | 11/28/2023 |
| Paley Jeffrey | ▼ Sell | Open Market | 255 | $959 | 11/8/2023 |
| Paley Jeffrey | ▼ Sell | Open Market | 2,245 | $8K | 11/7/2023 |
| Justin Adam Smith | ▲ Buy | Open Market | 33,000 | $98K | 10/13/2023 |
| Paley Jeffrey | ▲ Buy | Open Market | 15,000 | $45K | 10/6/2023 |
| Paley Jeffrey | ▲ Buy | Open Market | 30,000 | $89K | 9/21/2023 |
| Claude Maraoui | ▲ Buy | Open Market | 26,044 | $66K | 9/6/2023 |
| Lindsay A. Rosenwald, MD | ▲ Buy | Open Market | 100,000 | $223K | 9/6/2023 |
| Claude Maraoui | ▼ Sell | Open Market | 20,767 | $37K | 7/24/2023 |
| Joseph Benesch | ▼ Sell | Open Market | 4,072 | $7K | 7/24/2023 |
| Neil Herskowitz | ▲ Buy | Grant | 27,472 | $0 | 7/21/2023 |
| Paley Jeffrey | ▲ Buy | Grant | 27,472 | $0 | 7/21/2023 |
| Justin Adam Smith | ▲ Buy | Grant | 27,472 | $0 | 7/21/2023 |
| Miranda Jayne Toledano | ▲ Buy | Grant | 27,472 | $0 | 7/21/2023 |
| Claude Maraoui | ▼ Sell | Open Market | 24,377 | $33K | 5/17/2023 |
| Claude Maraoui | ▼ Sell | Open Market | 20,000 | $25K | 5/16/2023 |
| Joseph Benesch | ▼ Sell | Open Market | 2,768 | $5K | 2/22/2023 |
| De Paolantonio Ernest Robert | ▼ Sell | Open Market | 10,093 | $24K | 10/4/2022 |
| Lindsay A. Rosenwald, MD | ▲ Buy | Grant | 14,245 | $0 | 7/21/2022 |
| Justin Adam Smith | ▲ Buy | Grant | 14,245 | $0 | 7/21/2022 |
| Paley Jeffrey | ▲ Buy | Grant | 14,245 | $0 | 7/21/2022 |
| Neil Herskowitz | ▲ Buy | Grant | 14,245 | $0 | 7/21/2022 |
| Miranda Jayne Toledano | ▲ Buy | Grant | 14,245 | $0 | 7/21/2022 |
| Claude Maraoui | ▲ Buy | Grant | 300,000 | $0 | 7/21/2022 |
| De Paolantonio Ernest Robert | ▲ Buy | Grant | 150,000 | $0 | 7/21/2022 |
| Neil Herskowitz | ▲ Buy | Grant | 30,000 | $0 | 1/14/2022 |
| Miranda Jayne Toledano | ▲ Buy | Grant | 30,000 | $0 | 1/14/2022 |
| Paley Jeffrey | ▲ Buy | Grant | 30,000 | $0 | 1/14/2022 |
| Justin Adam Smith | ▲ Buy | Grant | 30,000 | $0 | 1/14/2022 |
| De Paolantonio Ernest Robert | ▲ Buy | Grant | 120,000 | $0 | 1/14/2022 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 27, 2026
Options Activity Signals Possible Move in Journey Medical (DERM)
Options traders are increasing positions in Journey Medical, hinting at a potential price move. The stock is near its 9‑touch support level of $6.05 and has recently touched the 200‑day SMA, adding to the technical backdrop. Analysts currently target a range of $13.00 to $15.00, well above the 52‑week high of $9.55.
Options Activity Signals Possible Move in Journey Medical (DERM). Options traders are increasing positions in Journey Medical, hinting at a potential price move. The stock is near its 9‑touch support level of $6.05 and has recently touched the 200‑day SMA, adding to the technical backdrop. Analysts currently target a range of $13.00 to $15.00, well above the 52‑week high of $9.55.